Rating History for Anacor Pharmaceuticals (ANAC) by Wedbush
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/17/2016 | N/A | Downgrade | Neutral (Outperform) |
99.25 (148.00) |
100.67 (10.19) |
-89.88% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/17/2016 | N/A | Downgrade | Neutral (Outperform) |
99.25 (148.00) |
100.67 (10.19) |
-89.88% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||